Who
Chan Henry Lee
SVP, General Counsel
Company insider
Files Form 4 as: SVP, General Counsel, BeOne Medicines.
In numbers
- Trades disclosed
- 204
- Buys
- 0
- Sells
- 28
- Bought
- $0
- Sold
- $20.5M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Jun 2023
- Last trade
- 30 Sep 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 2 Oct 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Sold | $418K1,115 at $375.00 | filing |
| 11 Aug 2026filed 13 Aug 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Code M | $158K812 at $194.47 | filing |
| 11 Aug 2026filed 13 Aug 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Code M | $226K1,058 at $213.32 | filing |
| 11 Aug 2026filed 13 Aug 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Code M | $127K796 at $159.03 | filing |
| 11 Aug 2026filed 13 Aug 2026 | ONC BeOne Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,556 at $0.00 | filing |
| 11 Aug 2026filed 13 Aug 2026 | ONC BeOne Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —13,754 at $0.00 | filing |
| 11 Aug 2026filed 13 Aug 2026 | ONC BeOne Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,348 at $0.00 | filing |
| 11 Aug 2026filed 13 Aug 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Sold | $960K2,666 at $360.00 | filing |
| 11 Aug 2026filed 13 Aug 2026 | ONC BeOne Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,556 at $0.00 | filing |
| 11 Aug 2026filed 13 Aug 2026 | ONC BeOne Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —13,754 at $0.00 | filing |
| 11 Aug 2026filed 13 Aug 2026 | ONC BeOne Medicinesoption or derivative · Biotechnology | SEC FORM 4 Code M | —10,348 at $0.00 | filing |
| 11 Aug 2026filed 13 Aug 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Code M | $158K812 at $194.47 | filing |
| 11 Aug 2026filed 13 Aug 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Code M | $226K1,058 at $213.32 | filing |
| 11 Aug 2026filed 13 Aug 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Code M | $127K796 at $159.03 | filing |
| 11 Aug 2026filed 13 Aug 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Sold | $960K2,666 at $360.00 | filing |
| 30 Jul 2026filed 3 Aug 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Sold | $338K1,044 at $323.69 | filing |
| 30 Jul 2026filed 3 Aug 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Sold | $338K1,044 at $323.69 | filing |
| 22 Jul 2026filed 24 Jul 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Code M | $100K514 at $194.47 | filing |
| 22 Jul 2026filed 24 Jul 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Code M | $142K665 at $213.32 | filing |
| 22 Jul 2026filed 24 Jul 2026 | ONC BeOne MedicinesBiotechnology | SEC FORM 4 Code M | $78K490 at $159.03 | filing |
News
BeOne Medicines (NASDAQ:ONC) Stock: Insider Chan Henry Lee Sells 1,115 Sharesthemarketsdaily.com · 2 Oct 2026Contrasting PainReform (NASDAQ:PRFX) & BeOne Medicines (NASDAQ:ONC)ONC · tickerreport.com · 21 Oct 2026
1 headline in the last 90 days name Chan Henry Lee; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.